In murine models of autoimmune diseases, H-151 has been shown to decrease IFN-1 production, which alleviates symptoms in models of systemic lupus erythematosus (SLE) and psoriasis (124). This evidence concerns the gene FUT1 and systemic lupus erythematosus.